IFN alpha-IFNAR-IN-1
98%
- Product Code: 100936
CAS:
844882-93-5
| Molecular Weight: | 279.4 g./mol | Molecular Formula: | C₁₈H₁₇NS |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
IFN alpha-IFNAR-IN-1 is primarily used in research settings to study the interferon (IFN) signaling pathway. It acts as an inhibitor of the interferon-alpha/beta receptor (IFNAR), making it a valuable tool for investigating the role of IFN signaling in immune responses, viral infections, and autoimmune diseases. Researchers utilize this compound to explore how blocking IFNAR affects cellular processes, cytokine production, and disease progression. Its application extends to preclinical studies aimed at developing therapeutic strategies for conditions where IFN signaling is dysregulated, such as lupus, multiple sclerosis, and certain cancers. Additionally, it helps in understanding the mechanisms of antiviral immunity and the potential for targeting IFN pathways in drug development.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿11,286.00 |
+
-
|
| 0.010 | 10-20 days | ฿17,235.00 |
+
-
|
IFN alpha-IFNAR-IN-1
IFN alpha-IFNAR-IN-1 is primarily used in research settings to study the interferon (IFN) signaling pathway. It acts as an inhibitor of the interferon-alpha/beta receptor (IFNAR), making it a valuable tool for investigating the role of IFN signaling in immune responses, viral infections, and autoimmune diseases. Researchers utilize this compound to explore how blocking IFNAR affects cellular processes, cytokine production, and disease progression. Its application extends to preclinical studies aimed at developing therapeutic strategies for conditions where IFN signaling is dysregulated, such as lupus, multiple sclerosis, and certain cancers. Additionally, it helps in understanding the mechanisms of antiviral immunity and the potential for targeting IFN pathways in drug development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :